AleAnna Total Liabilities 2022-2024 | ANNA

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AleAnna total liabilities from 2022 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

AleAnna total liabilities from 2022 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.

Related Stocks
Company Name	Market Cap
Zoetis (ZTS)	$73.4B
Chugai Pharmaceutical (CHGCY)	$72.5B
Takeda Pharmaceutical (TAK)	$42.2B
Merck (MKKGY)	$18.5B
Sandoz Group AG (SDZNY)	$17.9B
Astellas Pharma (ALPMY)	$17.4B
United Therapeutics (UTHR)	$16.1B
Neurocrine Biosciences (NBIX)	$14B
Summit Therapeutics (SMMT)	$13.5B
Shionogi (SGIOY)	$11.9B
Madrigal Pharmaceuticals (MDGL)	$6.8B
Orion OYJ (ORINY)	$6.2B
Ionis Pharmaceuticals (IONS)	$5.5B
Corcept Therapeutics (CORT)	$5.2B
Crinetics Pharmaceuticals (CRNX)	$4.8B
PTC Therapeutics (PTCT)	$3.5B
Recursion Pharmaceuticals (RXRX)	$2.8B
Dyne Therapeutics (DYN)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.4B
NewAmsterdam Pharma (NAMS)	$2.4B
Centessa Pharmaceuticals (CNTA)	$2.3B
Soleno Therapeutics (SLNO)	$2B
Indivior (INDV)	$1.7B
Xencor (XNCR)	$1.7B
BioCryst Pharmaceuticals (BCRX)	$1.6B
Evotec AG (EVO)	$1.5B
Ocular Therapeutix (OCUL)	$1.4B
Harrow (HROW)	$1.3B
Guardian Pharmacy Services (GRDN)	$1.3B